PF-Atlas › Клинические испытания › NCT02057458
Blood Flow and Vascular Function in Cystic Fibrosis
Sildenafil · Фаза 2
ID реестра
NCT02057458
Фаза
Фаза 2
Статус
Завершено
Препарат / вмешательство
Sildenafil (Acute-1 hour)
Спонсор
Augusta University
Начало
2014-04
Набор участников
19
Центры
1
Об исследовании
Cystic fibrosis (CF) has many health consequences. A reduction in the ability to perform exercise in patients with CF is related to greater death rates, steeper decline in lung function, and more frequent lung infections. However, the physiological mechanisms for this reduced exercise capacity are unknown. The investigators laboratory recently published the first evidence of systemic vascular dysfunction in patients with CF. Therefore, it is reasonable to suspect that the blood vessels are involved with exercise intolerance in CF. This study will look at how 1) blood flow and 2) artery function contribute to exercise capacity in CF.
Связанные материалы
Связанные исследования
Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT02057458 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.